Meta-Analysis of Transcatheter Closure Versus Medical Therapy for Patent Foramen Ovale in Prevention of Recurrent Neurological Events After Presumed Paradoxical Embolism
Top Cited Papers
- 1 July 2012
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 5 (7) , 777-789
- https://doi.org/10.1016/j.jcin.2012.02.021
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Study Design of the CLOSURE I TrialStroke, 2010
- Late Results After Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism Using the Amplatzer PFO Occluder Without Intraprocedural EchocardiographyJACC: Cardiovascular Interventions, 2009
- Recurrent Stroke and Massive Right-to-Left ShuntStroke, 2008
- Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: Periprocedural results and midterm risk of recurrent neurologic eventsAmerican Heart Journal, 2008
- Comparison of Three Patent Foramen Ovale Closure Devices in a Randomized Trial (Amplatzer Versus CardioSEAL-STARflex Versus Helex Occluder)The American Journal of Cardiology, 2008
- Percutaneous Closure of Patent Foramen Ovale: A Case Series and Literature ReviewClinical Medicine & Research, 2007
- Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up studyNeurological Sciences, 2006
- Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovaleInternational Journal of Cardiology, 2005
- Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attackAmerican Heart Journal, 1995
- Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention.Stroke, 1994